Skip to main content
. 2023 Dec;64(12):1956–1964. doi: 10.2967/jnumed.123.265418

TABLE 1.

Number of Mice with Objective Response, Stable Disease, and Progressive Disease at Week 4 After Treatment

Outcome [177Lu]Lu-DOTA-trastuzumab (10 MBq) (n = 9) [177Lu]Lu-DOTA-trastuzumab (5 MBq) (n = 8) [177Lu]Lu-DOTA-trastuzumab (5 MBq) + regimen 3 (n = 8)
Objective response 5 1 5
Stable disease 1 4 3
Progressive disease 3 3 0